Fig. 11From: ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinomaRelationship between the expression of STIL and several promising immunotherapeutic targets via the TIMER database. A–F The scatterplots of correlation between STIL expression and the promising immunotherapeutic targets (CD274, PDCD1, CTLA-4, LAG3, HAVCR2, and CD47. G The levels of promising immunotherapeutic targets between the high- and low-STIL expression groupsBack to article page